CDKN2B, SLC19A3 and DLEC1 Promoter Methylation Alterations in the Bone Marrow of Patients with Acute Myeloid Leukemia During Chemotherapy.
Experimental and Therapeutic Medicine（2016）
Key words
acute myeloid leukemia,chemotherapy,DNA methylation,cyclin-dependent kinase inhibitor 2B,solute carrier family 19 member 3,deleted in lung and esophageal cancer 1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined